There are dozens of brain training programs now available. In 2016, the FTC has been very actively enforcing existing consumer protection laws to stop brain game companies from making false advertisements and claims of efficacy. The ACTIVE study shows that speed training in particular reduces the risk of dementia, and that other forms of cognitive training do not. This means that any brain game or brain-training program that wants to state that it reduces the risk of dementia must go through a clinical trial like ACTIVE to establish that claim and a regulatory clearance process with the FDA. Posit Science has announced that it plans to seek clearance for this intended use from the FDA. Posit Science makes no claims at this time with respect to the efficacy of its offerings in preventing or treating any disease or disorder.
January 8, 2019